We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement
BioWisdom Launches Sofia KnowledgeScan™
Product News

BioWisdom Launches Sofia KnowledgeScan™

BioWisdom Launches Sofia KnowledgeScan™
Product News

BioWisdom Launches Sofia KnowledgeScan™


Want a FREE PDF version of This Product News?

Complete the form below and we will email you a PDF version of "BioWisdom Launches Sofia KnowledgeScan™"

First Name*
Last Name*
Email Address*
Country*
Company Type*
Job Function*
Would you like to receive further email communication from Technology Networks?

Technology Networks Ltd. needs the contact information you provide to us to contact you about our products and services. You may unsubscribe from these communications at any time. For information on how to unsubscribe, as well as our privacy practices and commitment to protecting your privacy, check out our Privacy Policy

BioWisdom has announced the launch of Sofia KnowledgeScan™. Sofia KnowledgeScan™ is designed to exploit BioWisdom’s Sofia Intelligence Platform to provide information to support critical healthcare-related decision making. 

Launched in response to customer feedback, Sofia KnowledgeScan™ enables a systematic analysis of available data to tease out intelligence that is relevant to specific commercially sensitive medical issues such as unexpected side-effects or toxicities. 

Rapid deployment of BioWisdom’s Healthcare Intelligence methodology is provided without the immediate need for technology installations and training. 

Clients will also have access to BioWisdom’s industry-trained specialised healthcare analysts, who can lead the research and present an unbiased expert opinion on the analysed data. 

"BioWisdom specialises in constructing Intelligence Networks, which provide a robust and intuitive method of navigating and analysing complex, multi-dimensional biomedical intelligence," said Gordon Smith Baxter, CEO of BioWisdom.

"Our competitive advantage lies in our combination of pharmaceutical R&D experience, our proprietary intelligence software and our robust methodology."

"We have developed our approach over several years working with international pharma companies, such as AstraZeneca, Pfizer, Johnson & Johnson, GSKEli Lilly and Roche." 

Advertisement